Gemcitabine plus carboplatin in patients with advanced non-small cell lung cancer
Gemcitabine plus carboplatin in patients with advanced non-small cell lung cancer
About this item
Full title
Author / Creator
Publisher
United States
Journal title
Language
English
Formats
Publication information
Publisher
United States
Subjects
More information
Scope and Contents
Contents
To evaluate the efficacy and safety of gemcitabine combined with carboplatin for a chemotherapy regimen for patients with metastatic, recurrent, or locally advanced non-small cell lung cancer (NSCLC), 46 chemotherapy-naïve patients with histologically confirmed stage IIIB or IV NSCLC were treated with 1250 mg/m(2) of gemcitabine on d 1 and 8, with...
Alternative Titles
Full title
Gemcitabine plus carboplatin in patients with advanced non-small cell lung cancer
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_crossref_primary_10_1385_MO_22_4_359
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1385_MO_22_4_359
Other Identifiers
ISSN
1357-0560
E-ISSN
1357-0560
DOI
10.1385/MO:22:4:359
